FY2024 EPS Estimates for Astrana Health Cut by William Blair

Astrana Health, Inc. (NASDAQ:ASTH) – Analysts at William Blair reduced their FY2024 earnings estimates for Astrana Health in a research note issued to investors on Thursday, November 7th. William Blair analyst R. Daniels now forecasts that the company will post earnings of $1.10 per share for the year, down from their previous estimate of $1.18. The consensus estimate for Astrana Health’s current full-year earnings is $1.31 per share. William Blair also issued estimates for Astrana Health’s Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.34 EPS and FY2025 earnings at $1.24 EPS.

Several other equities analysts have also issued reports on ASTH. BTIG Research lifted their price target on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Truist Financial boosted their price objective on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a report on Friday, August 9th. Stifel Nicolaus boosted their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. TD Cowen started coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 target price for the company. Finally, Robert W. Baird upped their price objective on shares of Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a research report on Thursday, August 15th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $62.00.

Astrana Health Stock Performance

Shares of ASTH stock opened at $46.81 on Monday. The firm has a market cap of $2.30 billion, a price-to-earnings ratio of 36.01, a PEG ratio of 1.79 and a beta of 1.24. The company’s 50 day moving average is $55.49 and its 200 day moving average is $47.68. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. Astrana Health has a 52-week low of $29.63 and a 52-week high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. The firm had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.57%. During the same quarter in the previous year, the firm posted $0.47 earnings per share.

Institutional Trading of Astrana Health

A number of institutional investors and hedge funds have recently modified their holdings of the stock. SteelPeak Wealth LLC purchased a new stake in Astrana Health during the 3rd quarter valued at about $39,398,000. NorthCrest Asset Manangement LLC purchased a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $26,704,000. Principal Financial Group Inc. purchased a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $13,383,000. F M Investments LLC purchased a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $11,738,000. Finally, Diamond Hill Capital Management Inc. purchased a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $8,245,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.